Nolte, Christian H. http://orcid.org/0000-0001-5577-1775
von Rennenberg, Regina
Litmeier, Simon
Scheitz, Jan F.
Leistner, David M.
Blankenberg, Stephan
Dichgans, Martin
Katus, Hugo
Petzold, Gabor C.
Pieske, Burkert
Regitz-Zagrosek, Vera
Wegscheider, Karl
Zeiher, Andreas M.
Landmesser, Ulf
Endres, Matthias
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung (DZHK 19)
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE B001)
Article History
Received: 27 March 2020
Accepted: 23 August 2020
First Online: 27 August 2020
Ethics approval and consent to participate
: The study was approved by the ethics committee at the coordinating center, Charite-Universitätsmedizin Berlin, Charitéplatz 1, 10117 D-Berlin, Germany ExternalRef removed) under the reference number EA1/057/18 and at all respective responsible ethics committees of all the participating centers. Written consent to participate must be obtained from the patient. The ethics committee approved the method of consent.
: The paper does not contain individual person’s data in any form.
: ME reports grants from Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo, Amgen, GSK, Sanofi, Covidien, Novartis, Pfizer, all outside the submitted work. CHN reports lecture fees and/or consultancies from Boehringer Ingelheim, BMS, Daiichi Sankyo, Sanofi, Pfizer, Abbott and Gore & Ass..